Teoman Soysal

948 total citations
77 papers, 393 citations indexed

About

Teoman Soysal is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Teoman Soysal has authored 77 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Hematology, 41 papers in Genetics and 21 papers in Pathology and Forensic Medicine. Recurrent topics in Teoman Soysal's work include Chronic Lymphocytic Leukemia Research (34 papers), Chronic Myeloid Leukemia Treatments (23 papers) and Lymphoma Diagnosis and Treatment (20 papers). Teoman Soysal is often cited by papers focused on Chronic Lymphocytic Leukemia Research (34 papers), Chronic Myeloid Leukemia Treatments (23 papers) and Lymphoma Diagnosis and Treatment (20 papers). Teoman Soysal collaborates with scholars based in Türkiye, Hungary and Germany. Teoman Soysal's co-authors include Muhlis Cem Ar, Ahmet Emre Eşkazan, Ayşe Salihoğlu, Zafer Başlar, Burhan Ferhanoğlu, Şeniz Öngören, Uğur Özbek, Yıldız Aydın, Gülen Hatemi and Tuğrul Elverdi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of Clinical Pathology.

In The Last Decade

Teoman Soysal

67 papers receiving 383 citations

Peers

Teoman Soysal
Ayşe Salihoğlu Türkiye
Mohamad Sobh France
Carla Filì Italy
Fumihiko Monma Japan
Ana Vidović Serbia
Toshiro Kawakita Japan
Violeta Kapsimali Greece
Antonella Di Mario Italy
Nobuhiro Hiramoto Japan
R Brown United States
Ayşe Salihoğlu Türkiye
Teoman Soysal
Citations per year, relative to Teoman Soysal Teoman Soysal (= 1×) peers Ayşe Salihoğlu

Countries citing papers authored by Teoman Soysal

Since Specialization
Citations

This map shows the geographic impact of Teoman Soysal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teoman Soysal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teoman Soysal more than expected).

Fields of papers citing papers by Teoman Soysal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teoman Soysal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teoman Soysal. The network helps show where Teoman Soysal may publish in the future.

Co-authorship network of co-authors of Teoman Soysal

This figure shows the co-authorship network connecting the top 25 collaborators of Teoman Soysal. A scholar is included among the top collaborators of Teoman Soysal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teoman Soysal. Teoman Soysal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hindilerden, Fehmi, et al.. (2025). A practical tool for predicting outcomes in essential thrombocythemia: Triple A risk model and beyond. Blood Advances. 10(4). 1250–1259.
2.
Yücesan, Emrah, Özden Hatırnaz Ng, Fevzi Yalniz, et al.. (2020). Copy-number variations in adult patients with chronic immune thrombocytopenia. Expert Review of Hematology. 13(11). 1277–1287. 3 indexed citations
3.
Salihoğlu, Ayşe, Teoman Soysal, Ìhsan Karadoǧan, et al.. (2019). Long-term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: multi-center real-life experience. Annals of Hematology. 99(2). 301–307. 5 indexed citations
4.
Soysal, Teoman, Ahmet Emre Eşkazan, Dilek Keskin, et al.. (2019). The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations. Clinical Lymphoma Myeloma & Leukemia. 19(7). e377–e384. 2 indexed citations
5.
Erbilgin, Yücel, Ahmet Emre Eşkazan, Özden Hatırnaz Ng, et al.. (2018). Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors. Leukemia & lymphoma. 60(1). 200–207. 11 indexed citations
6.
Salihoğlu, Ayşe, Ahmet Emre Eşkazan, Muhlis Cem Ar, et al.. (2017). Use of Bendamustine Combined with Rituximab in Chronic Lymphocytic Leukemia Patients: A Single Center Experience. Blood. 130. 5349–5349.
7.
8.
Yalniz, Fevzi, Ayşe Salihoğlu, Muhlis Cem Ar, et al.. (2017). Clinical Outcomes Related to the Use of Bendamustine Therapy for Multiple Myeloma Patients Relapsed-Refractory to IMiDs and Proteasome Inhibitors. Turkish Journal of Hematology. 34(3). 233–238. 2 indexed citations
9.
Eşkazan, Ahmet Emre, Mahir Cengız, Muhlis Cem Ar, et al.. (2016). Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemia. Journal of Clinical Pathology. 69(9). 810–816. 3 indexed citations
10.
Yemişen, Mücahit, İ̇lker İnanç Balkan, Ayşe Salihoğlu, et al.. (2016). The Changing Epidemiology of Bloodstream Infections and Resistance in Hematopoietic Stem Cell Transplantation Recipients. Turkish Journal of Hematology. 33(3). 216–222. 13 indexed citations
11.
Balkan, İ̇lker İnanç, et al.. (2013). Ecthyma Gangrenosum-like Lesions in a Febrile Neutropenic Patient with Simultaneous Pseudomonas Sepsis and Disseminated Fusariosis. SHILAP Revista de lepidopterología. 30(3). 321–324. 9 indexed citations
12.
Eşkazan, Ahmet Emre, et al.. (2013). B-Cell Chronic Lymphocytic Leukemia and Colon Adenocarcinoma in the Same Mesenteric Lymph Node. SHILAP Revista de lepidopterología. 30(1). 98–99. 1 indexed citations
13.
Eşkazan, Ahmet Emre, et al.. (2013). Postoperative thrombotic thrombocytopenic purpura. Surgery Today. 45(1). 8–16. 12 indexed citations
14.
Ar, Muhlis Cem, et al.. (2011). Variant Philadelphia translocations with different breakpoints in six chronic myeloid leukemia patients. SHILAP Revista de lepidopterología. 28(3). 186–192. 4 indexed citations
15.
Eşkazan, Ahmet Emre, Şeniz Öngören, Muhlis Cem Ar, et al.. (2011). Essential Thrombocythemia and Multiple Myeloma: Two Rare Diseases in One Patient. Clinical Lymphoma Myeloma & Leukemia. 11(5). 442–445. 9 indexed citations
16.
Eşkazan, Ahmet Emre, et al.. (2011). Thrombotic Thrombocytopenic Purpura After Prophylactic Cefuroxime Axetil Administered in Relation to a Liposuction Procedure. Aesthetic Plastic Surgery. 36(2). 464–467. 5 indexed citations
17.
Ar, Muhlis Cem, Zafer Başlar, Teoman Soysal, et al.. (2009). The Effect of ZAP-70 Expression on Disease Progression in Early-Stage (Binet A) B-CLL Patients. Balkan Medical Journal. 2009(4). 317–321. 1 indexed citations
18.
Öngören, Şeniz, Muhlis Cem Ar, Ahmet Emre Eşkazan, et al.. (2009). Clonal Chromosomal Abnormalities in Philadelphia-Negative Cells and Their Clinical Significance in Patients with Chronic Myeloid Leukemia: Results of a Single Center. Turkiye Klinikleri Tip Bilimleri Dergisi. 29(2). 321–330. 1 indexed citations
19.
Ng, Özden Hatırnaz, Muhlis Cem Ar, Cemaliye Boylu Akyerli, et al.. (2007). The SOCS‐1 gene methylation in chronic myeloid leukemia patients. American Journal of Hematology. 82(8). 729–730. 29 indexed citations
20.
Demirkesen, Cüyan, Nükhet Tüzüner, Özlem Su, et al.. (2004). Primary Cutaneous Immunocytoma/Marginal Zone B-Cell Lymphoma: A Case with Unusual Course. American Journal of Dermatopathology. 26(2). 119–122. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ayşe Salihoğlu Breakdown of academic impact, for papers by Mohamad Sobh Breakdown of academic impact, for papers by Carla Filì Breakdown of academic impact, for papers by Fumihiko Monma Breakdown of academic impact, for papers by Ana Vidović Breakdown of academic impact, for papers by Toshiro Kawakita Breakdown of academic impact, for papers by Violeta Kapsimali Breakdown of academic impact, for papers by Antonella Di Mario Breakdown of academic impact, for papers by Nobuhiro Hiramoto Breakdown of academic impact, for papers by R Brown
Rankless by CCL
2026